Low-cost diagnostic technologies and clinical outcomes. The impact of inappropriate utilization.
Commodification of low-cost diagnostic technologies (LCDTs) carries the risk of an unintended and potentially worrisome shift in how we conceive of health assessment. Optimizing practice requires a balanced understanding of both the beneficial and harmful impact of the use of LCDTs and the development of system incentives for appropriate use.
Lewis
S
S
Foreman
J
J
D003955:Diagnostic Tests, Routine / Q000191:economics / Q000592:standards / Q000706:statistics & numerical data*; D006291:Health Policy; D006801:Humans; D017063:Outcome Assessment, Health Care; D010818:Practice Patterns, Physicians'; D013673:Technology Assessment, Biomedical